Takeda Pharmaceutical
TAK
#491
Rank
C$65.54 B
Marketcap
C$19.70
Share price
0.28%
Change (1 day)
3.67%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : C$6.92 Billion

According to Takeda Pharmaceutical's latest financial reports the company has C$6.92 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31C$3.89 B-7.82%
2024-03-31C$4.22 B-24.81%
2023-03-31C$5.61 B-37.46%
2022-03-31C$8.98 B-21.05%
2021-03-31C$11.37 B32.96%
2020-03-31C$8.55 B-1.9%
2019-03-31C$8.72 B91.71%
2018-03-31C$4.54 B1.13%
2017-03-31C$4.49 B-30.44%
2016-03-31C$6.46 B-14.24%
2015-03-31C$7.54 B-17.24%
2014-03-31C$9.11 B50.36%
2013-03-31C$6.06 B9.21%
2012-03-31C$5.54 B-45.43%
2011-03-31C$10.16 B7.17%
2010-03-31C$9.48 B-1.92%
2009-03-31C$9.67 B-42.1%
2008-03-31C$16.70 B-5.57%
2007-03-31C$17.69 B-5.24%
2006-03-31C$18.67 B8.84%
2005-03-31C$17.15 B3.31%
2004-03-31C$16.60 B16.67%
2003-03-31C$14.23 B34.21%
2002-03-31C$10.60 B17.64%
2001-03-31C$9.01 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
C$25.71 B 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$14.47 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
C$20.75 B 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$13.50 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
C$1.71 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$1.08 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
C$13.08 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$6.15 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$25.23 B 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA